Acta Oto-Laryngologica
Acta Oto-Laryngologica is a peer-reviewed medical journal that focuses on the fields of otolaryngology, audiology, and speech therapy. The journal was first published in 1919 and is currently published by Taylor & Francis.
Overview[edit]
Acta Oto-Laryngologica publishes original research articles, review articles, and clinical reports related to the fields of otolaryngology, audiology, and speech therapy. The journal's primary aim is to disseminate significant clinical and basic research related to these fields. The journal is known for its rigorous peer-review process, ensuring that only high-quality, original research is published.
Scope[edit]
The scope of Acta Oto-Laryngologica includes, but is not limited to, the following areas:
- Otolaryngology: This branch of medicine deals with the diagnosis and treatment of diseases and disorders of the ear, nose, and throat (ENT), as well as related areas of the head and neck.
- Audiology: This is the science of hearing, balance, and related disorders. It involves the diagnosis and management of hearing loss and balance disorders in people of all ages.
- Speech therapy: This is the assessment and treatment of communication problems and speech disorders. It is performed by speech-language pathologists (SLPs), which are often referred to as speech therapists.
Abstracting and indexing[edit]
Acta Oto-Laryngologica is abstracted and indexed in several databases, including PubMed, Scopus, and the Science Citation Index. According to the Journal Citation Reports, the journal has a 2019 impact factor of 1.476.
See also[edit]
References[edit]
External links[edit]
-
Acta Oto-Laryngologica
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss blog | Philadelphia weight loss blog | Sleep medicine and sleep apnea services | W8MD MedSpa and wellness | Weight loss prescriptions
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian